• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4595230)   Today's Articles (9)   Subscriber (49331)
For: Inoue T, Sekito S, Kageyama T, Sugino Y, Sasaki T. Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment. Cancers (Basel) 2023;15:cancers15092662. [PMID: 37174127 PMCID: PMC10177034 DOI: 10.3390/cancers15092662] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2023] [Revised: 05/01/2023] [Accepted: 05/03/2023] [Indexed: 05/15/2023]  Open
Number Cited by Other Article(s)
1
Panzone J, Rood GJ, Goldberg H. The growing role of PARP inhibitors in the treatment of metastatic castration-resistant prostate cancer. Transl Cancer Res 2023;12:3233-3240. [PMID: 38192981 PMCID: PMC10774026 DOI: 10.21037/tcr-23-1515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Accepted: 10/20/2023] [Indexed: 01/10/2024]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA